Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.400
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.450
+0.050 (3.58%)
Pre-market: Apr 29, 2026, 7:40 AM EDT
Innate Pharma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 28.09 | 66.4 | 70.61 | 84.23 | 103.76 | Upgrade
|
| Short-Term Investments | 6.22 | 14.37 | 21.85 | 17.26 | 16.08 | Upgrade
|
| Cash & Short-Term Investments | 34.31 | 80.77 | 92.46 | 101.49 | 119.84 | Upgrade
|
| Cash Growth | -57.52% | -12.64% | -8.90% | -15.31% | -20.97% | Upgrade
|
| Accounts Receivable | 0.39 | 0.65 | 15.23 | 3.08 | 0.85 | Upgrade
|
| Other Receivables | 7.22 | 0.99 | 31.26 | 27.94 | 12.63 | Upgrade
|
| Receivables | 7.61 | 1.64 | 46.49 | 31.02 | 13.47 | Upgrade
|
| Prepaid Expenses | 2.39 | 2.82 | 5.69 | 4.67 | 2.58 | Upgrade
|
| Other Current Assets | 2.4 | 0.51 | 3.37 | 2.65 | 2.36 | Upgrade
|
| Total Current Assets | 46.71 | 85.74 | 148.01 | 139.83 | 138.26 | Upgrade
|
| Property, Plant & Equipment | 4.36 | 5.13 | 6.32 | 8.54 | 10.17 | Upgrade
|
| Long-Term Investments | 10.46 | 10.28 | 9.8 | 35.12 | 39.88 | Upgrade
|
| Other Intangible Assets | - | - | 0.42 | 1.56 | 44.19 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 5.03 | Upgrade
|
| Other Long-Term Assets | 1.2 | 9.9 | 10.64 | 14.25 | 29.97 | Upgrade
|
| Total Assets | 62.72 | 111.06 | 175.19 | 199.3 | 267.5 | Upgrade
|
| Accounts Payable | 7.48 | 7.92 | 8.56 | 13.66 | 14.73 | Upgrade
|
| Current Portion of Long-Term Debt | 8.52 | 8.44 | 8.45 | 1.28 | 29.94 | Upgrade
|
| Current Portion of Leases | 0.29 | 0.27 | 0.49 | 0.82 | 0.8 | Upgrade
|
| Current Income Taxes Payable | 6.55 | 6.96 | 7.02 | 5.98 | 7.46 | Upgrade
|
| Current Unearned Revenue | 9.33 | 8.06 | 13.51 | 16.78 | 19.92 | Upgrade
|
| Other Current Liabilities | 4.5 | 1.33 | 1.61 | 2.82 | 7.03 | Upgrade
|
| Total Current Liabilities | 36.65 | 32.98 | 39.64 | 41.34 | 79.89 | Upgrade
|
| Long-Term Debt | 13.67 | 22.18 | 30.61 | 38.93 | 11.49 | Upgrade
|
| Long-Term Leases | 0.1 | 0.1 | 0.35 | 1.22 | 2.01 | Upgrade
|
| Long-Term Unearned Revenue | 31.75 | 43.95 | 49.65 | 60.91 | 58.41 | Upgrade
|
| Pension & Post-Retirement Benefits | 1.92 | 2.73 | 2.44 | 2.55 | 2.98 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 5.03 | Upgrade
|
| Other Long-Term Liabilities | 0.33 | 0.27 | 0.6 | 0.2 | 0.25 | Upgrade
|
| Total Liabilities | 84.42 | 102.23 | 123.29 | 145.14 | 160.06 | Upgrade
|
| Common Stock | 4.69 | 4.19 | 4.04 | 4.01 | 3.98 | Upgrade
|
| Additional Paid-In Capital | 408.03 | 390.98 | 384.26 | 379.64 | 375.22 | Upgrade
|
| Retained Earnings | -435.54 | -386.36 | -336.89 | -330.32 | -272.21 | Upgrade
|
| Comprehensive Income & Other | 1.12 | 0.03 | 0.5 | 0.82 | 0.46 | Upgrade
|
| Shareholders' Equity | -21.7 | 8.83 | 51.9 | 54.15 | 107.44 | Upgrade
|
| Total Liabilities & Equity | 62.72 | 111.06 | 175.19 | 199.3 | 267.5 | Upgrade
|
| Total Debt | 22.57 | 31 | 39.89 | 42.25 | 44.25 | Upgrade
|
| Net Cash (Debt) | 11.74 | 49.78 | 52.56 | 59.23 | 75.59 | Upgrade
|
| Net Cash Growth | -76.42% | -5.30% | -11.26% | -21.63% | -42.98% | Upgrade
|
| Net Cash Per Share | 0.13 | 0.61 | 0.65 | 0.74 | 0.95 | Upgrade
|
| Filing Date Shares Outstanding | 93.79 | 92.16 | 80.86 | 80.19 | 79.54 | Upgrade
|
| Total Common Shares Outstanding | 93.7 | 83.83 | 80.86 | 80.19 | 79.54 | Upgrade
|
| Working Capital | 10.06 | 52.76 | 108.38 | 98.49 | 58.37 | Upgrade
|
| Book Value Per Share | -0.23 | 0.11 | 0.64 | 0.68 | 1.35 | Upgrade
|
| Tangible Book Value | -21.7 | 8.83 | 51.49 | 52.6 | 63.25 | Upgrade
|
| Tangible Book Value Per Share | -0.23 | 0.11 | 0.64 | 0.66 | 0.80 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.